Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
Published 26 June 2009, doi:10.1136/bmj.b2580
Cite this as: BMJ 2009;338:b2580
Adrian ODowd
1 London
| The first 150 words of the full text of this article appear below. |
NHS leaders have told MPs that the success in reducing well known infections that are acquired in hospital will lead to a reduction in other infections. The parliamentary public accounts committee quizzed witnesses this week as part of its inquiry into the National Audit Office report on reducing healthcare associated infections in hospitals, which was published earlier this month.
The MPs asked what next for these infections after concerns in the report that other infections would become a greater problem than meticillin resistant Staphylococcus aureus (MRSA) and Clostridium difficile.
The committee chairman, Edward Leigh, Conservative MP for Gainsborough, congratulated the NHS chief executive, David Nicholson, on the progress made on reducing MRSA and C difficile infections.
"This is a noticeable achievement, but it would be a pity if that was overshadowed by an upsurge in other infections, as appears to be happening at the moment," said Mr Leigh. "How
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
StumbleUpon
Technorati What's this?